Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-10-23

Clinical Trial Update: Effect of Pioglitazone Therapy for Type 2 Diabetes on Vision

View source ↗

Summary

This update indicates the UC San Diego-sponsored trial evaluating pioglitazone therapy for type 2 diabetes and its impact on vision has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University of California, San Diego | Conditions: Type 2 Diabetes | Status: COMPLETED